These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

994 related articles for article (PubMed ID: 33190346)

  • 21. COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?
    Liang F; Wang Y
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 and comorbidities of hepatic diseases in a global perspective.
    Ahmad A; Ishtiaq SM; Khan JA; Aslam R; Ali S; Arshad MI
    World J Gastroenterol; 2021 Apr; 27(13):1296-1310. PubMed ID: 33833483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brainstem Dysfunction in SARS-COV-2 Infection can be a Potential Cause of Respiratory Distress.
    Machado C; DeFina PA; Chinchilla M; Machado Y; Machado Y
    Neurol India; 2020; 68(5):989-993. PubMed ID: 33109839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.
    Galassi G; Marchioni A
    Acta Neurol Belg; 2021 Jun; 121(3):633-642. PubMed ID: 33811309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
    Lupu L; Palmer A; Huber-Lang M
    Front Immunol; 2020; 11():584514. PubMed ID: 33101314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver infection and COVID-19: the electron microscopy proof and revision of the literature.
    Pirisi M; Rigamonti C; D'Alfonso S; Nebuloni M; Fanni D; Gerosa C; Orrù G; Venanzi Rullo E; Pavone P; Faa G; Saba L; Boldorini R
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):2146-2151. PubMed ID: 33660834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and cellular mechanisms of liver dysfunction in COVID-19.
    Huang C; Li Q; Xu W; Chen L
    Discov Med; 2020; 30(160):107-112. PubMed ID: 33382966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy: A Concise Treatise.
    Joseph S; Nair B; Nath LR
    Curr Mol Med; 2021; 21(10):888-913. PubMed ID: 33563197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 and the liver - Lessons learned.
    Herta T; Berg T
    Liver Int; 2021 Jun; 41 Suppl 1(Suppl 1):1-8. PubMed ID: 34155789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients.
    Hartl L; Haslinger K; Angerer M; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Scheiner B; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Trauner M; Mandorfer M; Reiberger T
    Liver Int; 2022 Jun; 42(6):1297-1307. PubMed ID: 35412018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host determinants and responses underlying SARS-CoV-2 liver tropism.
    Heinen N; Klöhn M; Westhoven S; Brown RJ; Pfaender S
    Curr Opin Microbiol; 2024 Jun; 79():102455. PubMed ID: 38522265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis.
    Mawson AR; Croft AM; Gonzalez-Fernandez F
    Viral Immunol; 2021; 34(6):376-379. PubMed ID: 33983857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.
    Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW
    J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19: Catastrophic Cause of Acute Lung Injury.
    Cai A; McClafferty B; Benson J; Ramgobin D; Kalayanamitra R; Shahid Z; Groff A; Aggarwal CS; Patel R; Polimera H; Vunnam R; Golamari R; Sahu N; Bhatt D; Jain R
    S D Med; 2020 Jun; 73(6):252-260. PubMed ID: 32580257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tropism of Severe Acute Respiratory Syndrome Coronavirus 2 for Barrett's Esophagus May Increase Susceptibility to Developing Coronavirus Disease 2019.
    Jin RU; Brown JW; Li QK; Bayguinov PO; Wang JS; Mills JC
    Gastroenterology; 2021 May; 160(6):2165-2168.e4. PubMed ID: 33484686
    [No Abstract]   [Full Text] [Related]  

  • 36. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver injury in COVID-19: clinical features and treatment management.
    Yu D; Du Q; Yan S; Guo XG; He Y; Zhu G; Zhao K; Ouyang S
    Virol J; 2021 Jun; 18(1):121. PubMed ID: 34108015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute kidney injury associated with COVID-19-Cumulative evidence and rationale supporting against direct kidney injury (infection).
    Parmar MS
    Nephrology (Carlton); 2021 Mar; 26(3):239-247. PubMed ID: 33150674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
    Fuentes-Prior P
    J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2, alcohol consumption and liver injury.
    Testino G; DI Biagio A; Fagoonee S; Pellicano R
    Minerva Med; 2022 Apr; 113(2):333-342. PubMed ID: 34672164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.